Literature DB >> 1659272

Effects of long-term sulindac therapy on colonic polyposis.

J Rigau1, J M Piqué, E Rubio, R Planas, J M Tarrech, J M Bordas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1659272     DOI： 10.7326/0003-4819-115-12-952

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  34 in total

1.  Effects of sulindac on sporadic colorectal adenomatous polyps.

Authors:  N Matsuhashi; A Nakajima; Y Fukushima; Y Yazaki; T Oka
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 2.  Chemoprevention in familial adenomatous polyposis.

Authors:  Brian Kim; Francis M Giardiello
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-08       Impact factor: 3.043

3.  Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study.

Authors:  N Arber; S Kuwada; M Leshno; R Sjodahl; R Hultcrantz; D Rex
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

4.  Depressed-type early invasive colon cancer in a patient treated with cyclooxygenase-2 inhibitor.

Authors:  Tsukasa Kaihara; Kuang I Fu; Yasushi Sano; Keishi Yamashita; Atsushi Ochiai; Shigeaki Yoshida; Takahiro Fujimori
Journal:  Dig Dis Sci       Date:  2006-06-14       Impact factor: 3.199

5.  Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.

Authors:  Nan Li; Yaguang Xi; Heather N Tinsley; Evrim Gurpinar; Bernard D Gary; Bing Zhu; Yonghe Li; Xi Chen; Adam B Keeton; Ashraf H Abadi; Mary P Moyer; William E Grizzle; Wen-Chi Chang; Margie L Clapper; Gary A Piazza
Journal:  Mol Cancer Ther       Date:  2013-06-26       Impact factor: 6.261

6.  eRapa restores a normal life span in a FAP mouse model.

Authors:  Paul Hasty; Carolina B Livi; Sherry G Dodds; Diane Jones; Randy Strong; Martin Javors; Kathleen E Fischer; Lauren Sloane; Kruthi Murthy; Gene Hubbard; Lishi Sun; Vincent Hurez; Tyler J Curiel; Zelton Dave Sharp
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-26

7.  Proliferation-dependent changes in release of arachidonic acid from endothelial cells.

Authors:  R E Whatley; K Satoh; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect.

Authors:  W Kutchera; D A Jones; N Matsunami; J Groden; T M McIntyre; G A Zimmerman; R L White; S M Prescott
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

Authors:  Bernard F Cole; Richard F Logan; Susan Halabi; Robert Benamouzig; Robert S Sandler; Matthew J Grainge; Stanislas Chaussade; John A Baron
Journal:  J Natl Cancer Inst       Date:  2009-02-10       Impact factor: 13.506

Review 10.  Sulindac and polyp regression.

Authors:  F M Giardiello
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.